Clinical Trial Update: Standardization of Chortoglyphus Arcuatus Allergenic Extract. Determination of Biological Activity in HEP Units [Phase 2]

View source ↗

Summary

Phase 2 trial assessing standardization and biological activity of Chortoglyphus Arcuatus Allergenic Extract for allergic rhinitis and allergic conjunctivitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis
• Allergic Rhinitis

Drugs mentioned

• Chortoglyphus Arcuatus Allergenic Extract

Snippet

Sponsor: Laboratorios Leti, S.L. | Conditions: Rhinitis, Allergic, Seasonal, Conjunctivitis, Allergic | Phase 2 | Status: COMPLETED